Pramipexole vs cabergoline

Pramipexole and cabergoline are dopamine agonists used for managing conditions like Parkinson’s disease and hyperprolactinemia. Pramipexole targets brain dopamine receptors, easing symptoms such as tremors and stiffness while maintaining a favorable side-effect profile. Cabergoline treats elevated prolactin levels and offers benefits in Parkinson’s due to its long half-life, though caution is needed due to potential cardiac effects. The choice depends on the condition, patient tolerance, and side effects.

Select Wishlist

    Left Menu Icon
    Your Cart